(Q73269127)

English

Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies

scientific article published on 01 October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

author name string

L Ochoa

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H I Hurwitz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Wilding

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Cohen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J P Thomas

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Schwartz

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Monroe

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W P Petros

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

V P Ertel

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Hsieh

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Hoffman

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Drengler

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Magnum

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E K Rowinsky

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1313-1322

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic arterial chemotherapy for metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Population study of dihydropyrimidine dehydrogenase in cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical Basis for Circadian-Dependent Metabolism of Fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and alpha-fluoro-beta-alanine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Ethynyluracil (776C85): inactivation of dihydropyrimidine dehydrogenase in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving fluorouracil chemotherapy with novel orally administered fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008379802642

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008379802642

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106122%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73269127&oldid=1759435977"